Variant Bio is thrilled to announce that it has successfully raised $50,000,000 in its latest funding round—a remarkable milestone that marks a significant step forward in its mission to improve global health. This substantial investment will empower Variant Bio to expand its cutting-edge research and development efforts, focusing on the genetic study of individuals who are outliers for medically relevant traits. By delving deep into the unique genetic makeup of these exceptional cases, the company aims to unlock crucial insights that could lead to the discovery of novel therapeutic strategies for a wide range of diseases. The funding will be strategically allocated to accelerate preclinical research, enhance partnerships with academic and clinical institutions worldwide, and facilitate the development of innovative technologies that support efficient genetic analysis. As Variant Bio pushes the boundaries of traditional drug development, the fresh capital will also support the recruitment of top scientific talent and the expansion of its state-of-the-art laboratory facilities. This financial boost is not only an endorsement of the company’s groundbreaking approach but also a commitment to the broader global health agenda. By harnessing the power of genomics and precision medicine, Variant Bio is poised to make significant contributions toward new treatments that have the potential to transform patient outcomes. With a steadfast focus on innovation and impact, Variant Bio continues to pave the way for a new era in therapeutic development where enduring improvements in global health are within reach.
Variant Bio Raises $50M to Harness Genetic Outliers in Global Health Breakthroughs
Recently funded · $50.0MBiotechnology
Get the full Variant Bio company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
